LEP and metabolic syndrome: Both humans and mice with genetic loss of function mutations in either leptin or LepRb manifest severe early onset obesity ([104]–[108], insulin resistance [109], [110], dyslipidemia [111] and other metabolic, neuro-endocrine and immune dysfunctions.